Disease-burden-adapted immunotherapy protocol for primary refractory or high-risk relapsed pediatric acute lymphoblastic leukemia.

Sanaa KhanKrishnan VpYamini KrishnanGazel SainulabdinSomdipa PalRincy MathewsDarshan KatariaKunal SehgalPurva KanvindeLashkari HarshaprasadMinnie BodhanwalaBharat AgarwalAmbreen PandrowalaPrashant Hiwarkar

Published in: HemaSphere (2024)

Keyphrases

acute lymphoblastic leukemia
allogeneic hematopoietic stem cell transplantation
randomized controlled trial
risk factors
acute myeloid leukemia
diffuse large b cell lymphoma
multiple myeloma
young adults
hodgkin lymphoma